8VEC
 
 | Deep Mutational Scanning of SARS-CoV-2 PLpro | 分子名称: | Papain-like protease nsp3, ZINC ION | 著者 | Wu, X, Nguyen, J.V, Call, M.E, Call, M.J. | 登録日 | 2023-12-18 | 公開日 | 2024-03-20 | 最終更新日 | 2024-08-07 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape. Nat Commun, 15, 2024
|
|
9EMJ
 
 | SARS-CoV-2 methyltransferase nsp10-16 in complex with Toyocamycin and m7GpppA (Cap0-analog) | 分子名称: | 1,2-ETHANEDIOL, 2'-O-methyltransferase nsp16, 4-amino-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, ... | 著者 | Kremling, V, Sprenger, J, Oberthuer, D, Kiene, A. | 登録日 | 2024-03-08 | 公開日 | 2024-03-20 | 実験手法 | X-RAY DIFFRACTION (1.79 Å) | 主引用文献 | SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug development To Be Published
|
|
8VYE
 
 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, S2L20 Heavy Chain, S2L20 Light Chain, ... | 著者 | McCallum, M, Veesler, D, Seattle Structural Genomics Center for Infectious Disease (SSGCID) | 登録日 | 2024-02-08 | 公開日 | 2024-03-27 | 最終更新日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (2.7 Å) | 主引用文献 | Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun, 15, 2024
|
|
8VYF
 
 | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, S2L20 Heavy Chain, ... | 著者 | McCallum, M, Veesler, D, Seattle Structural Genomics Center for Infectious Disease (SSGCID) | 登録日 | 2024-02-08 | 公開日 | 2024-03-27 | 最終更新日 | 2024-11-06 | 実験手法 | ELECTRON MICROSCOPY (3.2 Å) | 主引用文献 | Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun, 15, 2024
|
|
8VYG
 
 | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, S309 Heavy Chain, S309 Light Chain, ... | 著者 | McCallum, M, Veesler, D, Seattle Structural Genomics Center for Infectious Disease (SSGCID) | 登録日 | 2024-02-08 | 公開日 | 2024-03-27 | 最終更新日 | 2025-01-08 | 実験手法 | ELECTRON MICROSCOPY (3.1 Å) | 主引用文献 | Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun, 15, 2024
|
|
8WLO
 
 | Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, ... | 著者 | Han, P, Yang, R.R, Li, S.H. | 登録日 | 2023-09-30 | 公開日 | 2024-03-27 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (2.62 Å) | 主引用文献 | Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2. J.Virol., 98, 2024
|
|
8WLR
 
 | Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hippopotamus ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, Spike glycoprotein, ... | 著者 | Han, P, Yang, R.R, Li, S.H. | 登録日 | 2023-09-30 | 公開日 | 2024-03-27 | 最終更新日 | 2024-10-23 | 実験手法 | ELECTRON MICROSCOPY (3.12 Å) | 主引用文献 | Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2. J.Virol., 98, 2024
|
|
8QZR
 
 | SARS-CoV-2 delta RBD complexed with BA.4/5-9 Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, BA.4/5-9 heavy chain, BA.4/5-9 light chain, ... | 著者 | Zhou, D, Ren, J, Stuart, D.I. | 登録日 | 2023-10-29 | 公開日 | 2024-04-03 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (3.77 Å) | 主引用文献 | Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nat Commun, 15, 2024
|
|
8S9Z
 
 | |
8F2X
 
 | |
8J39
 
 | Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF00835231 | 分子名称: | 3C-like proteinase nsp5, N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | 著者 | Zhou, X.L, Lin, C, Zou, X.F, Zhang, J, Li, J. | 登録日 | 2023-04-16 | 公開日 | 2024-04-17 | 最終更新日 | 2025-05-07 | 実験手法 | X-RAY DIFFRACTION (1.66 Å) | 主引用文献 | Structural basis for the inhibition of coronaviral main proteases by PF-00835231. Acta Biochim.Biophys.Sin., 56, 2024
|
|
8J3B
 
 | Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF00835231 | 分子名称: | 3C-like proteinase nsp5, N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | 著者 | Zhou, X.L, Lin, C, Zou, X.F, Zhang, J, Li, J. | 登録日 | 2023-04-16 | 公開日 | 2024-04-17 | 最終更新日 | 2025-05-07 | 実験手法 | X-RAY DIFFRACTION (1.64 Å) | 主引用文献 | Structural basis for the inhibition of coronaviral main proteases by PF-00835231. Acta Biochim.Biophys.Sin., 56, 2024
|
|
8KHC
 
 | SARS-CoV-2 Omicron spike in complex with 5817 Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Heavy chain of 5817 Fab, ... | 著者 | Cao, L, Wang, X. | 登録日 | 2023-08-21 | 公開日 | 2024-04-17 | 最終更新日 | 2025-06-25 | 実験手法 | ELECTRON MICROSCOPY (3 Å) | 主引用文献 | Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain. Cell Rep, 43, 2024
|
|
8KHD
 
 | The interface structure of Omicron RBD binding to 5817 Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Heavy chain of 5817, Light chain of 5817, ... | 著者 | Cao, L, Wang, X. | 登録日 | 2023-08-21 | 公開日 | 2024-04-17 | 最終更新日 | 2025-07-02 | 実験手法 | ELECTRON MICROSCOPY (3.5 Å) | 主引用文献 | Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain. Cell Rep, 43, 2024
|
|
8WZP
 
 | Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with CCF0058981 | 分子名称: | 2-(benzotriazol-1-yl)-~{N}-[(3-chlorophenyl)methyl]-~{N}-[4-(1~{H}-imidazol-5-yl)phenyl]ethanamide, 3C-like proteinase nsp5 | 著者 | Jiang, H.H, Zou, X.F, Zhou, X.L, Zhang, J, Li, J. | 登録日 | 2023-11-02 | 公開日 | 2024-04-17 | 実験手法 | X-RAY DIFFRACTION (1.76 Å) | 主引用文献 | Crystal structure of SARS-CoV-2 main protease (M pro ) mutants in complex with the non-covalent inhibitor CCF0058981. Biochem.Biophys.Res.Commun., 692, 2024
|
|
8WZQ
 
 | Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with CCF0058981 | 分子名称: | 2-(benzotriazol-1-yl)-~{N}-[(3-chlorophenyl)methyl]-~{N}-[4-(1~{H}-imidazol-5-yl)phenyl]ethanamide, 3C-like proteinase nsp5 | 著者 | Zou, X.F, Jiang, H.H, Zhou, X.L, Zhang, J, Li, J. | 登録日 | 2023-11-02 | 公開日 | 2024-04-17 | 実験手法 | X-RAY DIFFRACTION (1.66 Å) | 主引用文献 | Crystal structure of SARS-CoV-2 main protease (M pro ) mutants in complex with the non-covalent inhibitor CCF0058981. Biochem.Biophys.Res.Commun., 692, 2024
|
|
9EPL
 
 | Mpro from SARS-CoV-2 with 298Q mutation | 分子名称: | 1,2-ETHANEDIOL, GLYCEROL, Non-structural protein 11, ... | 著者 | Plewka, J, Lis, K, Czarna, A, Pyrc, K, Kantyka, T, Chykunova, Y. | 登録日 | 2024-03-18 | 公開日 | 2024-04-17 | 最終更新日 | 2024-04-24 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | SARS-CoV-2 M pro oligomerization as a potential target for therapy. Int.J.Biol.Macromol., 267, 2024
|
|
9EPM
 
 | Mpro from SARS-CoV-2 with 4A mutation | 分子名称: | Non-structural protein 11 | 著者 | Plewka, J, Lis, K, Czarna, A, Pyrc, K, Kantyka, T, Chykunova, Y. | 登録日 | 2024-03-19 | 公開日 | 2024-04-17 | 最終更新日 | 2024-04-24 | 実験手法 | X-RAY DIFFRACTION (1.981 Å) | 主引用文献 | SARS-CoV-2 M pro oligomerization as a potential target for therapy. Int.J.Biol.Macromol., 267, 2024
|
|
7YLD
 
 | |
8UD2
 
 | SARS-CoV-2 Nsp15, apo-form | 分子名称: | Non-structural protein 15 | 著者 | Ito, F, Yang, H, Zhou, Z.H, Chen, X.S. | 登録日 | 2023-09-28 | 公開日 | 2024-04-24 | 最終更新日 | 2024-07-10 | 実験手法 | ELECTRON MICROSCOPY (2.33 Å) | 主引用文献 | Structural basis for polyuridine tract recognition by SARS-CoV-2 Nsp15. Protein Cell, 15, 2024
|
|
8UD3
 
 | SARS-CoV-2 Nsp15 bound to poly(A/U) RNA, consensus form | 分子名称: | Non-structural protein 15, RNA (35-MER) | 著者 | Ito, F, Yang, H, Zhou, Z.H, Chen, X.S. | 登録日 | 2023-09-28 | 公開日 | 2024-04-24 | 最終更新日 | 2025-05-28 | 実験手法 | ELECTRON MICROSCOPY (2.67 Å) | 主引用文献 | Structural basis for polyuridine tract recognition by SARS-CoV-2 Nsp15. Protein Cell, 15, 2024
|
|
8WMF
 
 | Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state) | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein | 著者 | Nomai, T, Anraku, Y, Kita, S, Hashiguchi, T, Maenaka, K. | 登録日 | 2023-10-03 | 公開日 | 2024-04-24 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (2.51 Å) | 主引用文献 | Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol, 68, 2024
|
|
8XEA
 
 | |
8XI6
 
 | SARS-CoV-2 Omicron BQ.1.1 Variant Spike Protein Complexed with MO11 Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Ishimaru, H, Nishimura, M, Shigematsu, H, Marini, M.I, Hasegawa, N, Takamiya, R, Iwata, S, Mori, Y. | 登録日 | 2023-12-19 | 公開日 | 2024-04-24 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (2.3 Å) | 主引用文献 | Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein. J.Virol., 98, 2024
|
|
9ART
 
 | Crystal structure of SARS-CoV-2 main protease A191T mutant in complex with an inhibitor 5h | 分子名称: | 3C-like proteinase nsp5, N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | 著者 | Bulut, H, Hattori, S, Hayashi, H, Hasegawa, K, Li, M, Wlodawer, A, Tamamura, H, Mitsuya, H. | 登録日 | 2024-02-23 | 公開日 | 2024-04-24 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.49 Å) | 主引用文献 | Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2. Proc.Natl.Acad.Sci.USA, 121, 2024
|
|